tiprankstipranks
Alibaba Health Information Technology Ltd. (ALBHF)
OTHER OTC:ALBHF
Holding ALBHF?
Track your performance easily

Alibaba Health Information Technology (ALBHF) Income Statement

331 Followers

Alibaba Health Information Technology Income Statement

Last quarter (Q2 2023), Alibaba Health Information Technology's total revenue was ¥―, a decrease of ― from the same quarter last year. In Q2, Alibaba Health Information Technology's net income was ¥―. See Alibaba Health Information Technology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Mar 23Mar 22Mar 21Mar 20Mar 19
Total Revenue
--¥ 20.58B¥ 15.52B¥ 9.60B¥ 5.10B
Cost of Revenue
--¥ 16.47B¥ 11.90B¥ 7.37B¥ 3.76B
Gross Profit
--¥ 4.11B¥ 3.62B¥ 2.23B¥ 1.33B
Operating Expense
--¥ 5.13B¥ 3.51B¥ 2.27B¥ 1.42B
Operating Income
--¥ -1.02B¥ 110.83M¥ -42.15M¥ -93.33M
Net Non Operating Interest Income Expense
--¥ 206.02M¥ 162.97M¥ 34.25M¥ -2.91M
Other Income Expense
------
Pretax Income
--¥ -252.51M¥ 401.22M¥ 9.09M¥ -60.83M
Tax Provision
--¥ 13.43M¥ 58.54M¥ 24.79M¥ 30.93M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
--¥ -265.56M¥ 348.59M¥ -6.59M¥ -81.95M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
--¥ 21.60B¥ 15.41B¥ 9.64B¥ 5.19B
Net Income From Continuing And Discontinued Operation
--¥ -265.56M¥ 348.59M¥ -6.59M¥ -81.95M
Normalized Income
--¥ -591.71M¥ 231.04M¥ -54.27M¥ -104.52M
Interest Expense
--¥ 3.81M¥ 2.45M¥ 21.96M¥ 27.97M
EBIT
--¥ -248.70M¥ 403.67M¥ 31.06M¥ -32.86M
EBITDA
-¥ 620.55M¥ -188.12M¥ 443.29M¥ 72.75M¥ -28.88M
Currency in CNY

Alibaba Health Information Technology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis